UICentre announces a collaboration with the Center for Clinical and Translational Science (CCTS) to fund new drug discovery projects.
In Round 1 (February 2024), two awards of $30K were made.
In Round 2 (October 2024), one award of $50K was made.
The UICentre and the UI Cancer are continuing their collaboration to provide seed grants ($25K each) for promising new cancer therapeutic approaches. Today we announce our second round of awards, which are directed…
In Fall 2022, the University of Illinois Cancer Center (UICC) and UICentre joined forces to launch a new cancer drug discovery RFA entitled “U2D2”. Today we are announcing our first $25K awards: Identification…
Paul Carlier is the new director of UICentre, UIC's campus-wide drug discovery initiative that supports translational, "bench to bedside" scientific research. He also joins the Departments of Pharmaceutical Sciences & Chemistry as professor.
